Analysis - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

X

Advertise with us

Analysis

Tracing the story of mumps: a timeline

Could focusing on the user experience reinvent drug R&D software?

Poorly designed software leads to frustrated scientists and an inefficient R&D process. The Pistoia Alliance is promoting user experience principles to tackle this issue and accelerate life sciences innovation.

Pharma Technology Focus – Issue 70

In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre...

Could a new antibody screening method lead to better drugs?

A new technology can screen orders of magnitude more antibodies than existing methods. Elly Earls finds out why this breakthrough could vastly improve our understanding of how to leverage the...

US drug pricing: could the industry regulate itself?

Pharmaceutical price hikes are nothing new, but increased criticism from the public and politicians does seem to have instilled a new sense of social responsibility, at least for some companies....

Award-winning pharma packaging

Pharmapack Europe has revealed the winners of the 2018 Pharmapack Awards. Elliot Gardner profiles the six winning packaging systems, from a motor-driven disposable auto-injector to an all-in-one contactless multidose delivery...

Pharma Technology Focus – Issue 69

In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs,...

Shooting up: what does the future hold for growth drugs?

Growth drugs hold huge potential for various unmet clinical needs, including foetal growth restriction. But for better or for worse, these drugs are also sought after as supplements. Abi Millar...

Where are the pharma manufacturing hotspots?

Many countries around the globe have pushed local pharmaceutical production to the top of their agenda in recent years.

The racemisation risk: new tool could identify drugs destined to fail

Researchers have developed the first tool to systematically test the likelihood that a drug will undergo racemisation. This could be a major money-saver for pharma companies, as it could help...

Seamless trials: the key to more drug approvals?

The number of seamless clinical trials in the oncology space has spiked in recent years. Elly Earls meets researcher Dr Pedro Barata to find out about the benefits of this...